Profound Medical Corp. (PROF) Earnings Call Analysis

NASDAQ · Healthcare · Medical Devices

21/25

Growth 5 Margin 5 Expansion 4 Platform 4 Financial 3

latest quarter score

Earnings Reports

21
Profound Medical (PROF) Q2 2026: $70M Sales Pipeline Signals Inflection Despite Revenue Timing Shift
August 07, 2026
19
Profound Medical (PROF) Q1 2026: Revenue Doubles as Tulsa Platform Secures Major Payer Adoption
May 08, 2026
18
Profound Medical (PROF) Q4 2025: 43% Revenue Jump as Tulsa Pipeline Hits 110 Systems
March 06, 2026
20
Profound Medical (PROF) Q3 2025: Tulsa Pro Revenue Jumps 87% as BPH AI Launch Expands TAM
November 14, 2025
16
Profound Medical (PROF) Q2 2025: Gross Margin Jumps to 73% as Tulsa Pipeline Builds for Year-End Surge
August 14, 2025
16
Profound Medical (PROF) Q1 2025: Tulsa Revenue Jumps 82% as CAPTEN Trial Drives Adoption Pipeline
July 05, 2025

Browse all companies